In the past week, the U.S. President Donald Trump topped the headlines. On the first day of his second term, he signed plenty of executive orders. Investors are worrying about his economic policy most ...

（原标题：U.S. Economy Faces Major Risks, 2025 Could Be a Turning Point: Richard Roberts Sounds the Alarm） ...

As we move past the super electoral year of 2024, all eyes are now on 2025. With the return of “Trump 2.0,” what impact will ...

（以下内容从招银国际《Embracing AI and moving on to a new growth trajectory》研报附件原文摘录） 生益科技(600183) Shengyi Tech released its preliminary FY24 earnings. The company expects itsNP to rise by 46.0-54.6% YoY to RMB1 ...

1月21日，安徽休闲零食品牌三只松鼠（300783.SZ）发布2024年度业绩预告，公司预计实现营业收入102亿元-108亿元，同比增长43.37-51.80%；归属于上市公司股东的净利润为4.0亿元-4.2亿元，同比增长81.99-91.09%。

Willsemi released FY24 prelim results. Rev. is expected to grow by 20.9% to22.8% YoY to the range of RMB25.4bn to RMB25.8bn, driven by a higherpenetration rate of CIS products in high-end smartphone m ...

Investing.com -- 中国风险投资和私募股权公司HongShan资本集团已同意收购Marshall集团的多数股权。 HongShan资本集团（前身为Sequoia中国）从几个主要股东手中收购了股权。这些股东包括Altor、Telia Company、Time for Growth和Zenith VC。

海博思创成立于2011年， 是中国领先的电化学储能系统解决方案与技术服务提供商，为全球客户提供全系列储能系统产品及一站式整体解决方案。

尼古拉·坦根（Nicolai Tangen）是全球最大的主权财富基金（规模达约1.8万亿美元）的掌舵者，他身边总是不乏急切的投资者，他们希望从他那里获得跑赢市场的建议。

From groups of young women posing in front of Cinderella's castle at Shanghai Disneyland to families visiting the festive markets, South Koreans are taking advantage of China's visa-free policy that ...

在8个月的时间里，4家大型制药公司都披露了各自的并购案：诺华斥资10亿美元收购Mariana Oncology；礼来斥资14亿美元收购Point Biopharma；阿斯利康斥资24亿美元收购Fusion Pharmaceuticals；BMS斥资41亿美元收购RayzeBio。